Inhibition of bufalin on pituitary and testicular function in rats

Journal of Pharmacology and Experimental Therapeutics

Volumn 283, Issue 2, 1997, Pages 528-532

  Wang, Shyi Wu ^a   Chiao, Yu Chung ^b   Tsai, Shiow Chwen ^b   Lu, Chien Chen ^b   Chen, Jiann Jong ^b   Shih, Hsi Chang ^b   Chen, Yen Hao ^c   Lin, Ho ^b   Hwu, Chii Min ^d   Wang, Paulus S ^b  

^a CHANG GUNG UNIVERSITY   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c FU JEN CATHOLIC UNIVERSITY   (Taiwan)

^d TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

BUFALIN; CHORIONIC GONADOTROPIN; GONADORELIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HORMONAL REGULATION; HORMONE BLOOD LEVEL; HORMONE RESPONSE; HYPOPHYSIS; INTRAVENOUS DRUG ADMINISTRATION; LUTEINIZING HORMONE RELEASE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; TESTIS FUNCTION; TESTOSTERONE RELEASE;

1-METHYL-3-ISOBUTYLXANTHINE; ANIMALS; BUFANOLIDES; CARDIOTONIC AGENTS; CHORIONIC GONADOTROPIN; CYCLIC AMP; HUMANS; LUTEINIZING HORMONE; MALE; PITUITARY GLAND; RATS; RATS, SPRAGUE-DAWLEY; TESTIS; TESTOSTERONE;

EID: 9844253324     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. ANTMAN, E. M. AND SMITH, T. W.: Digitalis toxicity. Annu. Rev. Med. 36: 357-367, 1985.
2. BAGROV, A. Y., ROUKOYATKINA, N. I., FEDOROVA, O. V., PINAEV, A. G. AND UKHANOVA, M. V.: Digitalis-like and vasoconstrictor effects of endogenous digoxin-like factor(s) from the venom of Bufo marinus toad. Eur. J. Pharmacol. 234: 165-172, 1993.
3. 86Rb uptake by human erythrocytes. Clin. Sci. 78: 169-174, 1990.
4. DOHERTY, J. E., DE SOYZA, N., KANE, J. J., BISSETT, J. K. AND MURPHY, M. L.: Clinical pharmacokinetics of digitalis glycosides. Prog. Cardiovasc. Dis. 21: 141-158, 1978.
5. ELIADES, D., SWINDALL, B., JOHNSTON, J., PAMNANI, M. AND HADDY, F.: Hemodynamic effects of bufalin in the anesthetized dog. Hypertension 13: 690-695, 1989.
6. FUSHIMI, R., KOH, T., IYAMA, S., YASUHARA, M., TACHI, J., KOHDA, K., AMINO, N. AND MIYAI, K.: Digoxin-like immunoreactivity in Chinese medicine. Ther. Drug Monit. 12: 242-245, 1990.
7. HELLER, M.: Cardiac glycosides: new/old ideas about drugs. Biochem. Pharmacol. 40: 919-925, 1990.
8. HONG, Z., CHAN, K. AND YEUNG, H. W.: Simultaneous determination of bufadienolides in the traditional Chinese medicine preparation, Liu-Shen-Wan, by liquid chromatography. J. Pharm. Pharmacol. 44: 1023-1026, 1992.
9. HWANG, C., PU, H. F., HWANG, C. Y., LIU, J. Y., YAO, H. C., TUNG, Y. F. AND WANG, P. S.: Age-related differences in the release of luteinizing hormone and gonadotropin-releasing hormone in ovariectomized rats. Neuroendocrinology 52: 127-132, 1990.
10. KLEY, H. K., MULLER, A., PEERENBOOM, H. AND KRUSKEMPER, H. L.: Digoxin does not alter plasma steroid levels in healthy men. Clin. Pharmacol. Ther. 32: 12-17, 1982.
11. LOWRY, O. H., ROSEBROUGH, N. J., FARR, A. L. AND RANDALL, R. J.: Protein measurement with the folin phenol reagent. J. Biol. Chem. 193: 265-275, 1951.
12. LU, S. S., LAU, C. P., TUNG, Y. F., HUANG, S. W., CHEN, Y. H., SHIH, H. C., TSAI, S. C., LU, C. C., WANG, S. W., CHEN, J. J., CHIEN, E. J., CHIEN, C. H. AND WANG, P. S.: Lactate stimulates progesterone secretion via an increase in cAMP production in exercised female rats. Am. J. Physiol. 271: E910-E915, 1996.
13. NERI, A., ZUKERMAN, Z., AYGEN, M., LIDOR, Y. AND KAUFMAN, H.: The effect of long-term administration of digoxin on plasma androgens and sexual dysfunction. J. Sex. Marital. Ther. 13: 58-63, 1987.
14. PAMNANI, M. B., CHEN, S., BRYANT, H. J., SCHOOLEY, J. F., JR., ELIADES, D. C., YUAN, C. M. AND HADDY, F. J.: Effects of three sodium-potassium adenosine triphosphatase inhibitors. Hypertension 18: 316-324, 1991.
15. PAMNANI, M. B., CHEN, S., YUAN, C. M. AND HADDY, F. J.: Chronic blood pressure effects of bufalin, a sodium-potassium ATPase inhibitor, in rats. Hypertension 23: suppl. I, I106-I109, 1994.
16. PANESAR, N. S.: Bufalin radioimmunoassays: in search of the endogenous digitalis-like substance. J. Immunoassay 15: 371-391, 1994.
17. PITA, J. C. JR., LIPPMAN, M. E., THOMPSON, E. B. AND LORIAUX, D. L.: Interaction of spironolactone and digitalis with the 5α-dihydrotestosterone (DHT) receptor of rat ventral prostate. Endocrinology 97: 1521-1527, 1975.
18. RIETBROCK, N. AND WOODCOCK, B.: Two hundred years of foxglove therapy. Trends Pharmacol. Sci. 6: 267-269, 1985.
19. RIFKA, S. M., PITA, J. C., VIGERSKY, R. A., WILSON, Y. A. AND LORIZUX, D. L.: Interaction of digitalis and spironolactone with human sex steroid receptors. J. Clin. Endocrinol. Metab. 46: 338-344, 1977.
20. STEEL, R. D. AND TORRIE, J. H.: Principles and Procedures of Statistics, pp. 107-109, New York: McGraw-Hill, 1960.
21. STOFFER, S. S., HYNES, K. M., JIANG, N. S. AND RYAN, R. J.: Digoxin and abnormal serum hormone levels. JAMA 225: 1643-1644, 1973.
22. TAO, Q. F., SOSZYNSKI, P. A., HOLLENBERG, N. K. AND GRAVES, S. W.: A sensitive [Na, K] ATPase assay specific for inhibitors acting through the digitalis-binding site. J. Cardiovasc. Pharmacol. 25: 859-863, 1995.
23. TAPPLER, B. AND KATZ, M.: Pituitary-gonadal dysfunction in low-output cardiac failure. Clin. Endocrinol. 10: 219-226, 1979.
24. TSAI, S. C., CHIAO, Y. C., Lu, C. C., DOONG, M. L., CHEN, Y. H., SHIH, H. C., LIAW, C., WANG, S. W. AND WANG, P. S.: Inhibition by amphetamine of testosterone secretion through a mechanism involving an increase of cyclic AMP production in rat testes. Brit. J. Pharmacol., 118: 984-988, 1996.
25. WANG, P. S., TSAI, S. C., HWANG, G. S., WANG, S. W., L. U., C. C., CHEN, J. J., LIU, S. R., LEE, K. Y., CHIEN, C. H., LEE, H. Y., LAU, C. P. AND TSAI, C. L.: Calcitonin inhibits testosterone and luteinizing hormone secretion through a mechanism involving an increase in cAMP production in rats. J. Bone Miner. Res. 9: 1583-1590, 1994.
26. YATES, N. A. AND MCDOUGALL, J. G.: Effects of direct renal arterial infusion of bufalin and ouabain in conscious sheep. Br. J. Pharmacol., 108: 627-630, 1993.